Table 3.
Outcome |
Model 1
n = 485 257 |
Model 2
N = 399 297 |
Model 3
n = 399 297 |
---|---|---|---|
SHR (95% CI) | |||
Ischemic heart disease | 1.01 (0.99,1.02) | 1.00 (0.98,1.01) | 0.99 (0.98,1.01) |
Myocardial infarction | 1.00 (0.98,1.03) | 1.00 (0.98,1.02) | 1.00 (0.98,1.02) |
Non-ischemic cardiomyopathies | 0.96 (0.92,1.00) | 0.95 (0.91,0.99) | 0.95 (0.91,0.99)b |
Heart failure | 0.93 (0.91,0.95) | 0.92 (0.90,0.94) | 0.90 (0.89,0.92)b |
Atrial fibrillation | 0.98 (0.97,0.99) | 0.97 (0.95,0.98) | 0.95 (0.94,0.97)b |
CVD, cardiovascular disease; eBMD, estimated bone mineral density.
Denotes a statistically significant result.
Results are reported as sub-distribution hazard ratios (SHR) per 1-SD increment of eBMD obtained from Fine and Gray competing risks model. Model 1 is adjusted for age and sex. Model 2 is adjusted for age, sex, diabetes, hypertension, high cholesterol, smoking status, alcohol intake frequency, physical activity, Townsend score, and educational level. Model 3: Model 2 + BMI.